TreeWAS – Variant ID: rs12808148

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.958	0.042
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.958	0.042
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.962	0.038
T43.2 Other and unspecified antidepressants	0.000	0.963	0.037
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.964	0.036
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.966	0.034
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.966	0.034
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.966	0.034
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.967	0.033
T39.0 Salicylates	0.000	0.967	0.033
T40.4 Other synthetic narcotics	0.000	0.967	0.033
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.968	0.032
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.969	0.031
T43.9 Psychotropic drug, unspecified	0.000	0.970	0.030
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.970	0.030
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.970	0.030
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.971	0.029
T43.6 Psychostimulants with abuse potential	0.000	0.971	0.028
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.972	0.028
T36 Poisoning by systemic antibiotics	0.000	0.972	0.028
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.972	0.027
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.972	0.027
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.972	0.027
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.972	0.027
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.973	0.027
T39.4 Antirheumatics, not elsewhere classified	0.000	0.974	0.026
T39.2 Pyrazolone derivatives	0.000	0.974	0.026
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.974	0.026
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.974	0.026
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.974	0.026
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.975	0.025
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.975	0.025
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.975	0.025
T40.8 Lysergide [LSD]	0.000	0.975	0.025
T40.7 Cannabis (derivatives)	0.000	0.975	0.025
T40.5 Cocaine	0.000	0.975	0.025
T40.3 Methadone	0.000	0.975	0.025
T40.1 Heroin	0.000	0.975	0.025
T40.0 Opium	0.000	0.975	0.025
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.975	0.025
T42.0 Hydantoin derivatives	0.000	0.975	0.024
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.976	0.024
T40.6 Other and unspecified narcotics	0.000	0.976	0.023
T40.2 Other opioids	0.000	0.977	0.023
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.977	0.023
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.977	0.023
T42.3 Barbiturates	0.000	0.977	0.023
T42.2 Succinimides and oxazolidinediones	0.000	0.977	0.023
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.978	0.022
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.979	0.021
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.979	0.021
T47.7 Emetics	0.000	0.979	0.021
T47.6 Antidiarrhoeal drugs	0.000	0.979	0.021
T47.5 Digestants	0.000	0.979	0.021
T47.4 Other laxatives	0.000	0.979	0.021
T47.3 Saline and osmotic laxatives	0.000	0.979	0.021
T47.2 Stimulant laxatives	0.000	0.979	0.021
T47.0 Histamine H(2)-receptor antagonists	0.000	0.979	0.021
T46.1 Calcium-channel blockers	0.000	0.979	0.021
T42.1 Iminostilbenes	0.000	0.979	0.021
T36.0 Penicillins	0.000	0.979	0.021
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.979	0.020
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.979	0.020
T46.7 Peripheral vasodilators	0.000	0.979	0.020
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.979	0.020
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.979	0.020
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.979	0.020
T42.4 Benzodiazepines	0.000	0.979	0.021
T36.9 Systemic antibiotic, unspecified	0.000	0.980	0.020
T36.8 Other systemic antibiotics	0.000	0.980	0.020
T36.7 Antifungal antibiotics, systemically used	0.000	0.980	0.020
T36.6 Rifamycins	0.000	0.980	0.020
T36.5 Aminoglycosides	0.000	0.980	0.020
T36.4 Tetracyclines	0.000	0.980	0.020
T36.3 Macrolides	0.000	0.980	0.020
T36.2 Chloramphenicol group	0.000	0.980	0.020
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.980	0.020
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.980	0.020
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.980	0.020
T37.5 Antiviral drugs	0.000	0.980	0.020
T37.4 Anthelminthics	0.000	0.980	0.020
T37.3 Other antiprotozoal drugs	0.000	0.980	0.020
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.980	0.020
T37.1 Antimycobacterial drugs	0.000	0.980	0.020
T37.0 Sulphonamides	0.000	0.980	0.020
T41.5 Therapeutic gases	0.000	0.980	0.020
T41.4 Anaesthetic, unspecified	0.000	0.980	0.020
T41.3 Local anaesthetics	0.000	0.980	0.020
T41.2 Other and unspecified general anaesthetics	0.000	0.980	0.020
T41.1 Intravenous anaesthetics	0.000	0.980	0.020
T41.0 Inhaled anaesthetics	0.000	0.980	0.020
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.980	0.020
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.980	0.020
T48.5 Anti-common-cold drugs	0.000	0.980	0.020
T48.4 Expectorants	0.000	0.980	0.020
T48.3 Antitussives	0.000	0.980	0.020
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.980	0.020
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.980	0.020
T48.0 Oxytocic drugs	0.000	0.980	0.020
T49.9 Topical agent, unspecified	0.000	0.980	0.020
T49.8 Other topical agents	0.000	0.980	0.020
T49.7 Dental drugs, topically applied	0.000	0.980	0.020
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.980	0.020
T49.5 Ophthalmological drugs and preparations	0.000	0.980	0.020
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.980	0.020
T49.3 Emollients, demulcents and protectants	0.000	0.980	0.020
T49.2 Local astringents and local detergents	0.000	0.980	0.020
T49.1 Antipruritics	0.000	0.980	0.020
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.980	0.020
T39.1 4-Aminophenol derivatives	0.000	0.980	0.020
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.980	0.019
T38.9 Other and unspecified hormone antagonists	0.000	0.981	0.019
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.981	0.019
T38.7 Androgens and anabolic congeners	0.000	0.981	0.019
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.981	0.019
T38.5 Other oestrogens and progestogens	0.000	0.981	0.019
T38.4 Oral contraceptives	0.000	0.981	0.019
T38.2 Antithyroid drugs	0.000	0.981	0.019
T38.0 Glucocorticoids and synthetic analogues	0.000	0.981	0.019
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.981	0.019
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.981	0.019
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.981	0.019
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.981	0.019
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.981	0.019
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.981	0.019
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.981	0.019
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.981	0.019
T44.0 Anticholinesterase agents	0.000	0.981	0.019
T38.1 Thyroid hormones and substitutes	0.000	0.981	0.019
T50.8 Diagnostic agents	0.000	0.982	0.018
T50.7 Analeptics and opioid receptor antagonists	0.000	0.982	0.018
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.982	0.018
T50.5 Appetite depressants	0.000	0.982	0.018
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.982	0.018
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.982	0.018
T50.1 Loop [high-ceiling] diuretics	0.000	0.982	0.018
T50.0 Mineralocorticoids and their antagonists	0.000	0.982	0.018
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.982	0.018
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.982	0.018
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.982	0.018
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.982	0.018
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.983	0.017
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.983	0.017
T45.8 Other primarily systemic and haematological agents	0.000	0.983	0.017
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.983	0.017
T45.6 Fibrinolysis-affecting drugs	0.000	0.983	0.017
T45.4 Iron and its compounds	0.000	0.983	0.017
T45.3 Enzymes, not elsewhere classified	0.000	0.983	0.017
T45.2 Vitamins, not elsewhere classified	0.000	0.983	0.017
T45.0 Antiallergic and antiemetic drugs	0.000	0.983	0.017
T50.4 Drugs affecting uric acid metabolism	0.000	0.983	0.017
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.986	0.014
T45.5 Anticoagulants	0.000	0.988	0.012
N03.9 Unspecified	0.000	0.991	0.009
N81.1 Cystocele	0.008	0.992	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.993	0.007
N85.4 Malposition of uterus	0.007	0.993	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.000	0.994	0.006
C92.0 Acute myeloid leukaemia	0.000	0.994	0.006
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.000	0.994	0.006
Z36.0 Antenatal screening for chromosomal anomalies	0.006	0.994	0.000
S30.0 Contusion of lower back and pelvis	0.000	0.994	0.006
Z09.8 Follow-up examination after other treatment for other conditions	0.006	0.994	0.000
L53.9 Erythematous condition, unspecified	0.005	0.995	0.000
N03 Chronic nephritic syndrome	0.000	0.995	0.005
S30.1 Contusion of abdominal wall	0.000	0.995	0.005
I50.0 Congestive heart failure	0.000	0.995	0.005
Z36.8 Other antenatal screening	0.005	0.995	0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.000	0.995	0.005
S30.2 Contusion of external genital organs	0.000	0.995	0.005
Z36 Antenatal screening	0.005	0.995	0.000
K35.8 Acute appendicitis, other and unspecified	0.000	0.996	0.004
Z36.1 Antenatal screening for raised alphafetoprotein level	0.004	0.996	0.000
N03.8 Other	0.000	0.996	0.004
N03.7 Diffuse crescentic glomerulonephritis	0.000	0.996	0.004
N03.6 Dense deposit disease	0.000	0.996	0.004
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.996	0.004
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.996	0.004
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.996	0.004
N03.2 Diffuse membranous glomerulonephritis	0.000	0.996	0.004
N03.1 Focal and segmental glomerular lesions	0.000	0.996	0.004
N03.0 Minor glomerular abnormality	0.000	0.996	0.004
H50.9 Strabismus, unspecified	0.004	0.996	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.004	0.996	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.004	0.996	0.000
W19.2 School, other institution and public administrative area	0.000	0.996	0.004
Z36.5 Antenatal screening for isoimmunisation	0.003	0.996	0.000
S61.1 Open wound of finger(s) with damage to nail	0.003	0.997	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.003	0.997	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.997	0.003
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.997	0.003
L53 Other erythematous conditions	0.003	0.997	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.997	0.003
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
R22.1 Localised swelling, mass and lump, neck	0.000	0.997	0.003
Z75.1 Person awaiting admission to adequate facility elsewhere	0.000	0.997	0.003
R52.9 Pain, unspecified	0.003	0.997	0.000
L51.1 Bullous erythema multiforme	0.003	0.997	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.003	0.997	0.000
L53.3 Other chronic figurate erythema	0.002	0.997	0.000
L53.2 Erythema marginatum	0.002	0.997	0.000
L53.1 Erythema annulare centrifugum	0.002	0.997	0.000
L53.0 Toxic erythema	0.002	0.997	0.000
L51 Erythema multiforme	0.002	0.997	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.003	0.997	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.998	0.002
M19.94 Arthrosis, unspecified (Hand)	0.002	0.998	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.002	0.998	0.000
I50 Heart failure	0.000	0.998	0.002
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
H50.5 Heterophoria	0.002	0.998	0.000
L51.9 Erythema multiforme, unspecified	0.002	0.998	0.000
I50.9 Heart failure, unspecified	0.000	0.998	0.002
L50-L54 Urticaria and erythema	0.002	0.998	0.000
L30.8 Other specified dermatitis	0.002	0.998	0.000
N17.9 Acute renal failure, unspecified	0.002	0.998	0.000
G57.6 Lesion of plantar nerve	0.000	0.998	0.002
M75.0 Adhesive capsulitis of shoulder	0.000	0.998	0.002
Z36.9 Antenatal screening, unspecified	0.002	0.998	0.000
H50 Other strabismus	0.002	0.998	0.000
R22.0 Localised swelling, mass and lump, head	0.000	0.998	0.002
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.998	0.002
L50.9 Urticaria, unspecified	0.002	0.998	0.000
L50 Urticaria	0.002	0.998	0.000
M84.04 Malunion of fracture (Hand)	0.002	0.998	0.000
E66.8 Other obesity	0.002	0.998	0.000
L51.8 Other erythema multiforme	0.002	0.998	0.000
L51.2 Toxic epidermal necrolysis [Lyell]	0.002	0.998	0.000
L51.0 Nonbullous erythema multiforme	0.002	0.998	0.000
W44.8 Other specified place	0.002	0.998	0.000
L30.9 Dermatitis, unspecified	0.002	0.998	0.000
M84.03 Malunion of fracture (Forearm)	0.002	0.998	0.000
C22.1 Intrahepatic bile duct carcinoma	0.002	0.998	0.000
M84.0 Malunion of fracture	0.002	0.998	0.000
L53.8 Other specified erythematous conditions	0.002	0.998	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.998	0.002
K07.3 Anomalies of tooth position	0.002	0.998	0.000
L50.8 Other urticaria	0.002	0.998	0.000
C92 Myeloid leukaemia	0.000	0.998	0.002
H50.2 Vertical strabismus	0.002	0.998	0.000
M20.3 Other deformity of hallux (acquired)	0.000	0.998	0.002
R22.2 Localised swelling, mass and lump, trunk	0.000	0.998	0.002
L43 Lichen planus	0.002	0.998	0.000
C67.4 Posterior wall of bladder	0.000	0.998	0.002
L30 Other dermatitis	0.002	0.998	0.000
L54 Erythema in diseases classified elsewhere	0.002	0.998	0.000
M84.07 Malunion of fracture (Ankle and foot)	0.002	0.998	0.000
L43.8 Other lichen planus	0.002	0.998	0.000
N81.0 Female urethrocele	0.002	0.998	0.000
N76.4 Abscess of vulva	0.002	0.998	0.000
N81 Female genital prolapse	0.002	0.998	0.000
M84.01 Malunion of fracture (Shoulder region)	0.002	0.998	0.000
W44 Foreign body entering into or through eye or natural orifice	0.002	0.998	0.000
H50.8 Other specified strabismus	0.002	0.998	0.000
H50.6 Mechanical strabismus	0.002	0.998	0.000
H50.4 Other and unspecified heterotropia	0.002	0.998	0.000
H50.3 Intermittent heterotropia	0.002	0.998	0.000
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.998	0.002
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.002	0.998	0.000
D48.0 Bone and articular cartilage	0.002	0.998	0.000
K55.2 Angiodysplasia of colon	0.000	0.998	0.002
L30.1 Dyshidrosis [pompholyx]	0.002	0.998	0.000
W44.0 Home	0.002	0.998	0.000
L50.6 Contact urticaria	0.002	0.998	0.000
L50.5 Cholinergic urticaria	0.002	0.998	0.000
L50.4 Vibratory urticaria	0.002	0.998	0.000
L50.3 Dermatographic urticaria	0.002	0.998	0.000
L50.2 Urticaria due to cold and heat	0.002	0.998	0.000
D48.5 Skin	0.002	0.998	0.000
H52.0 Hypermetropia	0.002	0.998	0.000
L30.4 Erythema intertrigo	0.002	0.998	0.000
S81.0 Open wound of knee	0.002	0.998	0.000
L52 Erythema nodosum	0.002	0.998	0.000
K26.7 Chronic without haemorrhage or perforation	0.000	0.998	0.002
N81.3 Complete uterovaginal prolapse	0.002	0.998	0.000
O32.4 Maternal care for high head at term	0.002	0.998	0.000
M84.09 Malunion of fracture (Site unspecified)	0.002	0.998	0.000
M84.08 Malunion of fracture (Other)	0.002	0.998	0.000
M84.06 Malunion of fracture (Lower leg)	0.002	0.998	0.000
M84.05 Malunion of fracture (Pelvic region and thigh)	0.002	0.998	0.000
M84.00 Malunion of fracture (Multiple sites)	0.002	0.998	0.000
R22.3 Localised swelling, mass and lump, upper limb	0.000	0.998	0.002
M84.02 Malunion of fracture (Upper arm)	0.002	0.998	0.000
D48.1 Connective and other soft tissue	0.002	0.998	0.000
C21.1 Anal canal	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
N60.1 Diffuse cystic mastopathy	0.000	0.998	0.002
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
I50.1 Left ventricular failure	0.000	0.998	0.002
L43.3 Subacute (active) lichen planus	0.002	0.998	0.000
L43.2 Lichenoid drug reaction	0.002	0.998	0.000
L43.1 Bullous lichen planus	0.002	0.998	0.000
L43.0 Hypertrophic lichen planus	0.002	0.998	0.000
K51.8 Other ulcerative colitis	0.002	0.998	0.000
L30.5 Pityriasis alba	0.002	0.998	0.000
L30.3 Infective dermatitis	0.002	0.998	0.000
L30.2 Cutaneous autosensitisation	0.002	0.998	0.000
L30.0 Nummular dermatitis	0.002	0.998	0.000
L54.8 Erythema in other diseases classified elsewhere	0.001	0.998	0.000
L54.0 Erythema marginatum in acute rheumatic fever	0.001	0.998	0.000
A63.0 Anogenital (venereal) warts	0.002	0.998	0.000
C34.3 Lower lobe, bronchus or lung	0.002	0.998	0.000
J99.8 Respiratory disorders in other diseases classified elsewhere	0.000	0.998	0.002
L50.1 Idiopathic urticaria	0.001	0.998	0.000
T14.0 Superficial injury of unspecified body region	0.002	0.998	0.000
T18.5 Foreign body in anus and rectum	0.002	0.998	0.000
W44.9 Unspecified place	0.001	0.998	0.000
W44.5 Trade and service area	0.001	0.998	0.000
W44.7 Farm	0.001	0.998	0.000
W44.6 Industrial and construction area	0.001	0.998	0.000
W44.4 Street and highway	0.001	0.998	0.000
W44.3 Sports and athletics area	0.001	0.998	0.000
W44.2 School, other institution and public administrative area	0.001	0.998	0.000
W44.1 Residential institution	0.001	0.998	0.000
C92.7 Other myeloid leukaemia	0.000	0.998	0.001
N81.5 Vaginal enterocele	0.002	0.998	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.002	0.998	0.000
L50.0 Allergic urticaria	0.001	0.998	0.000
N00-N08 Glomerular diseases	0.000	0.998	0.002
N81.4 Uterovaginal prolapse, unspecified	0.002	0.998	0.000
W19.3 Sports and athletics area	0.000	0.998	0.002
W49.9 Unspecified place	0.001	0.998	0.000
Z75.4 Unavailability and inaccessibility of other helping agencies	0.000	0.998	0.001
C18.0 Caecum	0.000	0.998	0.002
W21.9 Unspecified place	0.001	0.998	0.000
O47.9 False labour, unspecified	0.002	0.998	0.000
W24.9 Unspecified place	0.001	0.998	0.000
M79.96 Soft tissue disorder, unspecified (Lower leg)	0.001	0.998	0.000
W27.6 Industrial and construction area	0.001	0.998	0.000
N04 Nephrotic syndrome	0.000	0.998	0.001
Z75 Problems related to medical facilities and other health care	0.000	0.998	0.001
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.001	0.999	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.000	0.999	0.001
T14.9 Injury, unspecified	0.001	0.999	0.000
T92.1 Sequelae of fracture of arm	0.001	0.999	0.000
H11 Other disorders of conjunctiva	0.001	0.999	0.000
W21 Striking against or struck by sports equipment	0.001	0.999	0.000
I86.1 Scrotal varices	0.001	0.999	0.000
Z39.0 Care and examination immediately after delivery	0.001	0.999	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.001	0.999	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.001	0.999	0.000
W27 Contact with nonpowered hand tool	0.001	0.999	0.000
W44.59 Foreign body entering into or through eye or natural orifice; Trade and service area;During unspecified activity	0.001	0.999	0.000
W44.99 Foreign body entering into or through eye or natural orifice, Unspecified place , During unspecified activity	0.001	0.999	0.000
J20.9 Acute bronchitis, unspecified	0.001	0.999	0.000
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.001	0.999	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.999	0.001
D48.7 Other specified sites	0.001	0.999	0.000
D48.4 Peritoneum	0.001	0.999	0.000
D48.3 Retroperitoneum	0.001	0.999	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.001	0.999	0.000
N04.9 Unspecified	0.000	0.999	0.001
N08 Glomerular disorders in diseases classified elsewhere	0.000	0.999	0.001
W20-W49 Exposure to inanimate mechanical forces	0.001	0.999	0.000
H11.8 Other specified disorders of conjunctiva	0.001	0.999	0.000
H11.1 Conjunctival degenerations and deposits	0.001	0.999	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.000	0.999	0.001
N06 Isolated proteinuria with specified morphological lesion	0.000	0.999	0.001
N01 Rapidly progressive nephritic syndrome	0.000	0.999	0.001
N00 Acute nephritic syndrome	0.000	0.999	0.001
W25.8 Other specified place	0.001	0.999	0.000
W25 Contact with sharp glass	0.001	0.999	0.000
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.000	0.999	0.001
O32.1 Maternal care for breech presentation	0.001	0.999	0.000
W29 Contact with other powered hand tools and household machinery	0.001	0.999	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.999	0.001
N81.9 Female genital prolapse, unspecified	0.001	0.999	0.000
W49.6 Industrial and construction area	0.001	0.999	0.000
Z75.8 Other problems related to medical facilities and other health care	0.000	0.999	0.001
Z75.2 Other waiting period for investigation and treatment	0.000	0.999	0.001
T14 Injury of unspecified body region	0.001	0.999	0.000
G44.0 Cluster headache syndrome	0.000	0.999	0.001
H11.2 Conjunctival scars	0.001	0.999	0.000
N04.8 Other	0.000	0.999	0.001
N04.7 Diffuse crescentic glomerulonephritis	0.000	0.999	0.001
N04.6 Dense deposit disease	0.000	0.999	0.001
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.999	0.001
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.999	0.001
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.999	0.001
N04.2 Diffuse membranous glomerulonephritis	0.000	0.999	0.001
N04.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
N04.0 Minor glomerular abnormality	0.000	0.999	0.001
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.001	0.999	0.000
Z75.9 Unspecified problem related to medical facilities and other health care	0.000	0.999	0.001
Z75.0 Medical services not available in home	0.000	0.999	0.001
H11.9 Disorder of conjunctiva, unspecified	0.001	0.999	0.000
H11.3 Conjunctival haemorrhage	0.001	0.999	0.000
H50.0 Convergent concomitant strabismus	0.001	0.999	0.000
R23.1 Pallor	0.000	0.999	0.001
W21.3 Sports and athletics area	0.001	0.999	0.000
W21.8 Other specified place	0.001	0.999	0.000
W21.7 Farm	0.001	0.999	0.000
W21.6 Industrial and construction area	0.001	0.999	0.000
W21.5 Trade and service area	0.001	0.999	0.000
W21.4 Street and highway	0.001	0.999	0.000
W21.2 School, other institution and public administrative area	0.001	0.999	0.000
W21.1 Residential institution	0.001	0.999	0.000
W21.0 Home	0.001	0.999	0.000
W24.8 Other specified place	0.001	0.999	0.000
W24.7 Farm	0.001	0.999	0.000
W24.6 Industrial and construction area	0.001	0.999	0.000
W24.5 Trade and service area	0.001	0.999	0.000
W24.4 Street and highway	0.001	0.999	0.000
W24.3 Sports and athletics area	0.001	0.999	0.000
W24.2 School, other institution and public administrative area	0.001	0.999	0.000
W24.1 Residential institution	0.001	0.999	0.000
W24.0 Home	0.001	0.999	0.000
W29.9 Unspecified place	0.001	0.999	0.000
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.001	0.999	0.000
G71.0 Muscular dystrophy	0.000	0.999	0.001
W27.9 Unspecified place	0.001	0.999	0.000
W27.0 Home	0.001	0.999	0.000
W27.8 Other specified place	0.001	0.999	0.000
W27.7 Farm	0.001	0.999	0.000
W27.5 Trade and service area	0.001	0.999	0.000
W27.4 Street and highway	0.001	0.999	0.000
W27.3 Sports and athletics area	0.001	0.999	0.000
W27.2 School, other institution and public administrative area	0.001	0.999	0.000
W27.1 Residential institution	0.001	0.999	0.000
W49.8 Other specified place	0.001	0.999	0.000
W49.7 Farm	0.001	0.999	0.000
W49.5 Trade and service area	0.001	0.999	0.000
W49.4 Street and highway	0.001	0.999	0.000
W49.3 Sports and athletics area	0.001	0.999	0.000
W49.2 School, other institution and public administrative area	0.001	0.999	0.000
W49.1 Residential institution	0.001	0.999	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.000	0.999	0.001
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.000	0.999	0.001
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.000	0.999	0.001
N08.1 Glomerular disorders in neoplastic diseases	0.000	0.999	0.001
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.000	0.999	0.001
W46 Contact with hypodermic needle	0.001	0.999	0.000
W43 Exposure to vibration	0.001	0.999	0.000
W42 Exposure to noise	0.001	0.999	0.000
W41 Exposure to high-pressure jet	0.001	0.999	0.000
W40 Explosion of other materials	0.001	0.999	0.000
W39 Discharge of firework	0.001	0.999	0.000
W38 Explosion and rupture of other specified pressurised devices	0.001	0.999	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.001	0.999	0.000
W36 Explosion and rupture of gas cylinder	0.001	0.999	0.000
W35 Explosion and rupture of boiler	0.001	0.999	0.000
W34 Discharge from other and unspecified firearms	0.001	0.999	0.000
W33 Rifle, shotgun and larger firearm discharge	0.001	0.999	0.000
W32 Handgun discharge	0.001	0.999	0.000
W31 Contact with other and unspecified machinery	0.001	0.999	0.000
W30 Contact with agricultural machinery	0.001	0.999	0.000
W28 Contact with powered lawn mower	0.001	0.999	0.000
W26 Contact with knife, sword or dagger	0.001	0.999	0.000
K35.3 Acute appendicitis with localized peritonitis	0.000	0.999	0.001
N00.9 Unspecified	0.000	0.999	0.001
N00.8 Other	0.000	0.999	0.001
N00.7 Diffuse crescentic glomerulonephritis	0.000	0.999	0.001
N00.6 Dense deposit disease	0.000	0.999	0.001
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.999	0.001
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.999	0.001
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.999	0.001
N00.2 Diffuse membranous glomerulonephritis	0.000	0.999	0.001
N00.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
N00.0 Minor glomerular abnormality	0.000	0.999	0.001
N01.9 Unspecified	0.000	0.999	0.001
N01.8 Other	0.000	0.999	0.001
N01.7 Diffuse crescentic glomerulonephritis	0.000	0.999	0.001
N01.6 Dense deposit disease	0.000	0.999	0.001
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.999	0.001
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.999	0.001
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.999	0.001
N01.2 Diffuse membranous glomerulonephritis	0.000	0.999	0.001
N01.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
N01.0 Minor glomerular abnormality	0.000	0.999	0.001
N06.9 Unspecified	0.000	0.999	0.001
N06.8 Other	0.000	0.999	0.001
N06.7 Diffuse crescentic glomerulonephritis	0.000	0.999	0.001
N06.6 Dense deposit disease	0.000	0.999	0.001
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.999	0.001
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.999	0.001
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.999	0.001
N06.2 Diffuse membranous glomerulonephritis	0.000	0.999	0.001
N06.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
N06.0 Minor glomerular abnormality	0.000	0.999	0.001
N07.9 Unspecified	0.000	0.999	0.001
N07.8 Other	0.000	0.999	0.001
N07.7 Diffuse crescentic glomerulonephritis	0.000	0.999	0.001
N07.6 Dense deposit disease	0.000	0.999	0.001
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.999	0.001
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.999	0.001
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.999	0.001
N07.2 Diffuse membranous glomerulonephritis	0.000	0.999	0.001
N07.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
N07.0 Minor glomerular abnormality	0.000	0.999	0.001
T17.9 Foreign body in respiratory tract, part unspecified	0.001	0.999	0.000
W25.6 Industrial and construction area	0.001	0.999	0.000
W25.5 Trade and service area	0.001	0.999	0.000
W25.1 Residential institution	0.001	0.999	0.000
W25.0 Home	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations